# Protalix BioTherapeutics, Inc.: Form 8-K, filed Mar 18, 2011

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2011-03-18
- Accepted by EDGAR: Mar 18, 2011, 06:02 ET
- Period: 2011-03-17
- Accession: 0000950123-11-026581
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000095012311026581/y04669e8vk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000095012311026581/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000095012311026581/y04669e8vk.htm

Filed Mar 18, 2011.
Source: SEC EDGAR, the filing index for accession 0000950123-11-026581. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
